- €578.73m
- €566.97m
- €224.92m
- 93
- 44
- 90
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 17.96 | ||
| PEG Ratio (f) | 12.6 | ||
| EPS Growth (f) | 1.45% | ||
| Dividend Yield (f) | 4.28% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.25 | ||
| Price to Tang. Book | 12.48 | ||
| Price to Free Cashflow | 14.82 | ||
| Price to Sales | 2.41 | ||
| EV to EBITDA | 7.87 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 44.47% | ||
| Return on Equity | 48.96% | ||
| Operating Margin | 22.22% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 124.33 | 122.63 | 172.73 | 198.45 | 224.92 | 223 | 227 | 15.53% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +8.19 | +8.88 | +96.8 | +9.92 | +19.16 | -15.18 | +7.49 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The Company operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. The Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others.
Directors
- Bang Chen CHM (55)
- Eduardo Baviera Sabater CEO
- Virgilio Leal Espi CFO
- Marcos Bueso Sanchis GED
- Sofia Querol Videgain OTH
- Diego Ramos Pascual SEC
- Li Li DRC (55)
- Shijun Wu DRC (48)
- Yongmei Zhang DRC (61)
- Ricardo Moreno Warleta IND
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 31st, 1992
- Public Since
- January 1st, 2000
- No. of Employees
- 1,326
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Madrid Stock Exchange- Shares in Issue
- 16,302,373
- Address
- Paseo de la Castellana 20, MADRID, 28046
- Web
- https://www.clinicabaviera.com/
- Phone
- +34 917819880
- Auditors
- PricewaterhouseCoopers Auditores SL
Upcoming Events for CBAV
Q4 2024 Clinica Baviera SA Earnings Release
Similar to CBAV
Atrys Health SA
Madrid Stock Exchange
Euroespes SA
Madrid Stock Exchange
FAQ
What is the Clinica Baviera SA share price?
As of Today at 20:00 UTC, shares in Clinica Baviera SA are trading at €35.50. This share price information is delayed by 15 minutes.
How has the Clinica Baviera SA share price performed this year?
Shares in Clinica Baviera SA last closed at €35.50 and the price had moved by +73.17% over the past 365 days. In terms of relative price strength the Clinica Baviera SA share price has outperformed the FTSE Global All Cap Index by +49.4% over the past year.
What are the analyst and broker recommendations for Clinica Baviera SA?
The overall consensus recommendation for Clinica Baviera SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Clinica Baviera SA dividend yield?
The Clinica Baviera SA dividend yield is 4.42% based on the trailing twelve month period.
Does Clinica Baviera SA pay a dividend?
Last year, Clinica Baviera SA paid a total dividend of €1.57, and it currently has a trailing dividend yield of 4.42%. We do not have any data on when Clinica Baviera SA is to next pay dividends.
When does Clinica Baviera SA next pay dividends?
We do not have data on when Clinica Baviera SA is to next pay dividends. The historic dividend yield on Clinica Baviera SA shares is currently 4.42%.
How do I buy Clinica Baviera SA shares?
To buy shares in Clinica Baviera SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Clinica Baviera SA?
As of the previous close price of €35.50, shares in Clinica Baviera SA had a market capitalisation of €578.73m.
Where are Clinica Baviera SA shares listed?
Here are the trading details for Clinica Baviera SA:
- Country of listing: Spain
- Exchange: MCE
- Ticker Symbol: CBAV
What kind of share is Clinica Baviera SA?
Based on an overall assessment of its quality, value and momentum Clinica Baviera SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Clinica Baviera SA share price forecast for 2024?
The analyst consensus target price for shares in Clinica Baviera SA is €24.30. That is 31.55% below the last closing price of €35.50.
Analysts covering Clinica Baviera SA currently have a consensus Earnings Per Share (EPS) forecast of €1.87 for the next financial year.
Find out moreWhat is the trend in the Clinica Baviera SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clinica Baviera SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +21.47%.
As of the last closing price of €35.50, shares in Clinica Baviera SA were trading +25.86% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Clinica Baviera SA PE Ratio?
The Clinica Baviera SA PE ratio based on its reported earnings over the past 12 months is 17.96. The shares last closed at €35.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Clinica Baviera SA?
Clinica Baviera SA's management team is headed by:
- Bang Chen - CHM
- Eduardo Baviera Sabater - CEO
- Virgilio Leal Espi - CFO
- Marcos Bueso Sanchis - GED
- Sofia Querol Videgain - OTH
- Diego Ramos Pascual - SEC
- Li Li - DRC
- Shijun Wu - DRC
- Yongmei Zhang - DRC
- Ricardo Moreno Warleta - IND